Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,205,641
+$376,097 QoQ
Shares Held
12,739
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#1,609
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WRIGHT INVESTORS SERVICE INC holds $24,294,827 across 7 Drug Manufacturers - General names. ABBV ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
55,467 | $7,007,700 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
72,470 | $4,175,720 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,422 | $3,523,727 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
12,739 | $3,205,641 | |
| 5 | LLY |
ELI LILLY & Co
|
2,517 | $3,018,965 | |
| 6 | AMGN |
Amgen Inc
|
7,030 | $2,545,703 | |
| 7 | PFE |
Pfizer Inc
|
33,944 | $817,371 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,205,641 | 12,739 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,829,544 | 13,010 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,885,472 | 17,005 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,530,521 | 15,248 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,668,779 | 19,765 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $8,025,872 | 38,306 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $6,127,095 | 34,480 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $9,582,913 | 48,526 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $7,657,681 | 44,646 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $9,184,941 | 50,439 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $7,170,771 | 46,272 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,937,656 | 39,834 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $5,289,095 | 39,257 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,667,722 | 41,838 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $6,770,166 | 41,892 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $7,098,098 | 52,888 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $8,288,100 | 54,114 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $6,828,883 | 42,125 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $5,632,369 | 41,598 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $4,219,227 | 39,114 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $4,800,378 | 42,617 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $3,787,267 | 34,996 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $4,393,900 | 41,007 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $4,239,093 | 48,397 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $4,984,009 | 50,764 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,292,925 | 56,345 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||